SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Step Pharma to Present Phase 2 Dencatistat Data at ASH Meeting

Step Pharma says it will present data from its ongoing phase 2 trial of dencatistat in essential thrombocythaemia. The company describes this as the first clinical data from its ET programme; the supplied body is truncated before further details.

Related stories